{
    "root": "30275089-d967-7dd8-e063-6294a90adb10",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Azithromycin",
    "value": "20250312",
    "ingredients": [
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (70000 WAMW)",
            "code": "66O7AQV0RT"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "HYPROMELLOSE 2910 (15 MPA.S)",
            "code": "36SFW2JZ0W"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "D&C RED NO. 30",
            "code": "2S42T2808B"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "AZITHROMYCIN DIHYDRATE",
            "code": "5FD1131I7S"
        }
    ],
    "indications": "azithromycin tablets macrolide antibacterial indicated treatment patients mild moderate infections caused susceptible strains designated microorganisms conditions listed . recommended dosages durations therapy adult pediatric patient vary [ ( 2 ) ] .",
    "contraindications": "\u2022 adult patients ( 2.1 ) infection recommended dose/duration therapy community-acquired pneumonia ( mild severity ) pharyngitis/tonsillitis ( second-line therapy ) skin/skin structure ( uncomplicated ) 500 mg single dose day 1 , followed 250 mg daily days 2 5. acute bacterial exacerbations chronic bronchitis ( mild moderate ) 500 mg single dose day 1 , followed 250 mg daily days 2 5 500 mg daily 3 days . acute bacterial sinusitis 500 mg daily 3 days . genital ulcer disease ( chancroid ) non-gonococcal urethritis cervicitis one single 1 gram dose . gonococcal urethritis cervicitis one single 2 gram dose . \u2022 pediatric patients ( 2.2 ) infection recommended dose/duration therapy acute otitis media ( 6 months age older ) 30 mg/kg single dose 10 mg/kg daily 3 days 10 mg/kg single dose day 1 followed 5 mg/kg/day days 2 5. acute bacterial sinusitis ( 6 months age older ) 10 mg/kg daily 3 days . community-acquired pneumonia ( 6 months age older ) 10 mg/kg single dose day 1 followed 5 mg/kg daily days 2 5. pharyngitis/tonsillitis ( 2 years age older ) 12 mg/kg daily 5 days .",
    "warningsAndPrecautions": "azithromycin tablets usp , 500 mg supplied pink modified capsule shaped , film-coated tablet debossed \u201c 591 \u201d one side \u201c l \u201d side containing azithromycin dihydrate equivalent 500 mg azithromycin , usp . ndc : 70518-3254-00 ndc : 70518-3254-01 ndc : 70518-3254-02 ndc : 70518-3254-03 ndc : 70518-3254-04 packaging : 30 1 blister pack packaging : 2 1 bottle plastic packaging : 2 1 box packaging : 1 1 pouch packaging : 3 1 bottle plastic store 25\u00b0c ( 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . repackaged distributed : remedy repack , inc. 625 kolter dr. suite # 4 indiana , pa 1-724-465-8762",
    "adverseReactions": "\u00b7 patients known hypersensitivity azithromycin , erythromycin , macrolide ketolide . ( 4.1 ) \u00b7 patients history cholestatic jaundice/hepatic dysfunction associated prior azithromycin . ( 4.2 )",
    "indications_original": "Azithromycin tablets are a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications \n       \n \n  [see Dosage and Administration (2)].",
    "contraindications_original": "\u2022\u00a0Adult Patients (2.1) Infection Recommended Dose/Duration of Therapy Community-acquired pneumonia (mild severity) Pharyngitis/tonsillitis (second-line therapy) Skin/skin structure (uncomplicated) 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5. Acute bacterial exacerbations of chronic bronchitis (mild to moderate) 500 mg as a single dose on Day 1, followed by 250 mg once daily on Days 2 through 5 or 500 mg once daily for 3 days. Acute bacterial sinusitis 500 mg once daily for 3 days. Genital ulcer disease (chancroid) Non-gonococcal urethritis and cervicitis One single 1 gram dose. Gonococcal urethritis and cervicitis One single 2 gram dose. \u2022 Pediatric Patients (2.2) Infection Recommended Dose/Duration of Therapy Acute otitis media (6 months of age and older) 30 mg/kg as a single dose or 10 mg/kg once daily for 3 days or 10 mg/kg as a single dose on Day 1 followed by 5 mg/kg/day on Days 2 through 5. Acute bacterial sinusitis (6 months of age and older) 10 mg/kg once daily for 3 days. Community-acquired pneumonia (6 months of age and older) 10 mg/kg as a single dose on Day 1 followed by 5 mg/kg once daily on Days 2 through 5. Pharyngitis/tonsillitis (2 years of age and older) 12 mg/kg once daily for 5 days.",
    "warningsAndPrecautions_original": "Azithromycin tablets USP, 500 mg are supplied as pink modified capsule shaped, film-coated tablet debossed with \u201c591\u201d on one side and \u201cL\u201d on the other side containing azithromycin dihydrate equivalent to 500 mg of azithromycin, USP.\n                  NDC: 70518-3254-00\n                  NDC: 70518-3254-01\n                  NDC: 70518-3254-02\n                  NDC: 70518-3254-03\n                  NDC: 70518-3254-04\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  PACKAGING: 2 in 1 BOTTLE PLASTIC\n                  PACKAGING: 2 in 1 BOX\n                  PACKAGING: 1 in 1 POUCH\n                  PACKAGING: 3 in 1 BOTTLE PLASTIC\n                  \n                  Store at 25\u00b0C (77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [see USP Controlled Room Temperature].\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions_original": "\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Patients with known hypersensitivity to azithromycin, erythromycin, any macrolide or ketolide drug. (4.1) \u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Patients with a history of cholestatic jaundice/hepatic dysfunction associated with prior use of azithromycin. (4.2)"
}